Not logged in
Home     Markets     Shares     Funds     Portfolio     Toolbox  Watchlists Latest Results SENS Search Ranking Tables Director Dealings Calendar Events Dividends Corporate Events Listings/Delistings/Renamed Consensus Forecasts Unit Trust Holdings    Charting     Alerts     Directory  JSE Stockbrokers JSE Sponsors NSX Brokers/Sponsors FTSE/JSE RI Index Africa Top Stocks Stock Exchange Ebook     – Latest Issue    – Archive Newsletters Sharepaedia FAQs/Help      Admin  Free Registration Subscribe My Account Terms and Conditions Contact Us About ShareData Online    Login

Registration Successful. Thank you for registering. We have emailed a password to Please check your email, enter the password we've sent you and click LOGIN to continue.
You need to be logged on as a free registered user or subscriber for this link. Please log in or see below for free registration, subscription or free trial.
You need a premium subscription for this link to work. Please see below for free registration, premium subscription or free trial.
Email : Password :	(For free registration, leave blank and click Login)
	Login Forgotten your password?
Having trouble with this screen? Email us or phone 011-728-5510
Need a password? Registration is FREE! Just enter an email address above and click the LOGIN button (leave the password field blank)
Free registration is required to access customise options, watchlists, portfolios and the alert service so that we can protect your privacy and keep track of your selections. We undertake never to abuse your email address. If you are an ex-subscriber, free trial user or newsletter recipient you are automatically a free user – just click here and we'll email you a password reminder. If you've never registered before, enter an email address above (leave password field blank) and click LOGIN - we'll send you a password immediately.
Need a subscription? Take the inside track, become a PREMIUM user
Subscribers to ShareData Online have access to professional-level information – the same data used by financial markets specialists and fund managers. Subscription rates for private investors are very reasonable – the equivalent of a weekly grande latte.   Click here for the subscription sign-up page
Or sign up for a free trial... Full access for 10 days, no strings attached
If you'd like to preview our PREMIUM content, please sign up for a free trial.     We do NOT ask for credit card details. At the end of the free trial, if you choose not to subscribe, you will automatically be a free registered user with access to watchlists, portfolios and alerts.     The free trial gives full access to all of ShareData Online for 10 days.     Please click here for the free trial sign-up page.

Email address

When you click the 'Send' button an email will be sent to the above email address
containing the password that is registered for the email address.

I accept the Terms and Conditions of Subscription & Privacy Policy

Fedsure Holdings Limited
(Incorporated in the Republic of South Africa)
(Registered number 1969/012384/06)
("Fedsure")
Company Announcement
Shareholders are advised that Fedsure Healthcare (Proprietary) Limited has
disposed of the pharmaceutical benefit management business of Mediscor to a
consortium comprising management and RMB Ventures ("the disposal"). The
disposal is subject to certain conditions precedent, including inter alia,
the approval of the Competition Commission. The disposal will have no
material effect on the earnings and net asset value per Fedsure share.
Sandton
22 August 2001
Sponsor
Investec Securities Limited
Member of the JSE
Registration No. 1972/008905/06
Attorneys
Cliffe Dekker Fuller Moore Inc
(Registration number 1998/018173/21)

Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.

Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site

[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]

Powered by ProfileData Profile Mobile App Follow us on: